Literature DB >> 26300030

Personalized Medicine and Mood Disorders.

Lujain Alhajji1, Charles B Nemeroff2.   

Abstract

Some of the latest advances in personalized psychiatry with future research directions are discussed in this article. Many factors contribute to the phenotypic psychiatric profile in individual patients. These overlapping factors include but are not limited to genetics, epigenetics, central nervous system circuit alterations, family history, past personal history, environmental influences including early life stress, and more recent life stressors. The authors discuss the role of pharmacogenomics, particularly in the cytochrome P450 enzyme system in relation to treatment response. Despite some promising advances in personalized medicine in psychiatry, it is still in its early phases of development.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bipolar disorder; Epigenetics; Major depressive disorder; Personalized medicine; Pharmacogenomics; Precision medicine

Mesh:

Year:  2015        PMID: 26300030     DOI: 10.1016/j.psc.2015.05.003

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  7 in total

1.  Precision Medicine: The new era in medicine.

Authors:  Marinka Twilt
Journal:  EBioMedicine       Date:  2016-02-08       Impact factor: 8.143

Review 2.  Four Actionable Bottlenecks and Potential Solutions to Translating Psychiatric Genetics Research: An Expert Review.

Authors:  Jessica L Bourdon; Rachel A Davies; Elizabeth C Long
Journal:  Public Health Genomics       Date:  2020-11-04       Impact factor: 2.000

3.  The Holy Grail of Psychiatry.

Authors:  Charles B Nemeroff
Journal:  Cerebrum       Date:  2015-08-01

4.  Effects of Postnatal Enriched Environment in a Model of Parkinson's Disease in Adult Rats.

Authors:  Adel Jungling; Dora Reglodi; Zsofia Nozomi Karadi; Gabor Horvath; Jozsef Farkas; Balazs Gaszner; Andrea Tamas
Journal:  Int J Mol Sci       Date:  2017-02-14       Impact factor: 5.923

Review 5.  From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways.

Authors:  G B Rogers; D J Keating; R L Young; M-L Wong; J Licinio; S Wesselingh
Journal:  Mol Psychiatry       Date:  2016-04-19       Impact factor: 15.992

6.  The functional variant rs334558 of GSK3B is associated with remission in patients with depressive disorders.

Authors:  Anastasia Levchenko; Innokentiy S Losenkov; Natalia M Vyalova; German G Simutkin; Nikolay A Bokhan; Bob Wilffert; Anton Jm Loonen; Svetlana A Ivanova
Journal:  Pharmgenomics Pers Med       Date:  2018-07-20

Review 7.  Current challenges and possible future developments in personalized psychiatry with an emphasis on psychotic disorders.

Authors:  Anastasia Levchenko; Timur Nurgaliev; Alexander Kanapin; Anastasia Samsonova; Raul R Gainetdinov
Journal:  Heliyon       Date:  2020-05-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.